Head and Neck Neoplasms

Displaying 1 - 23 of 23CSV
Mazul, A. L., Barrett, T. F., Colditz, G., Parikh, A. S., Ramadan, S., Zevallos, J. P., Rich, J. T., Harbison, R. A., Jackson, R. S., Pipkorn, P., Zolkind, P., Tirosh, I., & Puram, S. V. (2024). A hybrid epithelial/mesenchymal state in head and neck cancer: A biomarker for survival with differential prognosis by self-reported race. Med, 5(7), 826-831.e3. https://doi.org/10.1016/j.medj.2024.05.014
Publication Date
Darragh, L. B., Nguyen, A., Pham, T. T., Idlett-Ali, S., Knitz, M. W., Gadwa, J., Bukkapatnam, S., Corbo, S., Olimpo, N. A., Nguyen, D., Van Court, B., Neupert, B., Yu, J., Ross, R. B., Corbisiero, M., Abdelazeem, K. N. M., Maroney, S. P., Galindo, D. C., Mukdad, L., … Karam, S. D. (2024). Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs. Med, 5(3), 254-270.e8. https://doi.org/10.1016/j.medj.2024.02.002
Publication Date
Chen, F., Tang, C., Yang, F., Ekpenyong, A., Qin, R., Xie, J., Momen-Heravi, F., Saba, N. F., & Teng, Y. (2024). HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science Advances, 10(8). https://doi.org/10.1126/sciadv.adk3663
Publication Date
Hilton, J. F., Ott, P. A., Hansen, A. R., Li, Z., Mathew, M., Messina, C. H., Dave, V., Ji, X., Karpinich, N. O., Hirschfeld, S., Ballas, M., & Zandberg, D. P. (2024). INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors. Cancer Immunology, Immunotherapy, 73(3). https://doi.org/10.1007/s00262-023-03623-z
Publication Date
Baris, M. M., Quarterman, P., Shin, J., Fung, M. M., Jambawalikar, S. R., & Moonis, G. (2023). Diagnostic Utility of Restriction Spectrum Imaging in Head and Neck Tumors: A Pilot Study. Journal of Computer Assisted Tomography, 48(1), 150–155. https://doi.org/10.1097/rct.0000000000001513
Publication Date
Morgado-Palacin, L., Brown, J. A., Martinez, T. F., Garcia-Pedrero, J. M., Forouhar, F., Quinn, S. A., Reglero, C., Vaughan, J., Heydary, Y. H., Donaldson, C., Rodriguez-Perales, S., Allonca, E., Granda-Diaz, R., Fernandez, A. F., Fraga, M. F., Kim, A. L., Santos-Juanes, J., Owens, D. M., Rodrigo, J. P., … Ferrando, A. A. (2023). The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-36713-8
Publication Date
Muthupalani, S., Annamalai, D., Feng, Y., Ganesan, S. M., Ge, Z., Whary, M. T., Nakagawa, H., Rustgi, A. K., Wang, T. C., & Fox, J. G. (2023). IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-39907-8
Publication Date
Park, S. J., Min, H. J., Yoon, C., Kim, S. H., Kim, J. H., & Lee, S. Y. (2023). Integrin β1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness. Cellular Signalling, 110, 110808. https://doi.org/10.1016/j.cellsig.2023.110808
Publication Date
Hall, J., Yanagihara, T. K., & Wang, T. J. C. (2023). Commentary: Fractionated Radiotherapy After Gross Total Resection of Clival Chordoma: A Systematic Review of Survival Outcomes. Neurosurgery, 93(2), e19–e20. https://doi.org/10.1227/neu.0000000000002445
Publication Date
Kao, D. D., Ferrandino, R. M., Roof, S. A., Marshall, D. C., Khan, M. N., Chai, R. L., Park, Y. A., & Sigel, K. M. (2023). Neutrophil‐to‐lymphocyte ratio as a predictor of surgical outcomes in head and neck cancer. Head & Neck, 45(8), 1903–1912. Portico. https://doi.org/10.1002/hed.27402
Publication Date
Li, J., Momen‐Heravi, F., Wu, X., & He, K. (2022). Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells. Oral Diseases, 29(5), 2012–2026. Portico. https://doi.org/10.1111/odi.14220
Publication Date
Stanbouly, D., Goudarzi, F., Ashshi, R. A., Patel, N., Chandra, S. R., & DMD, S.-K. C. (2023). Is health insurance a risk factor for suicidal ideation among adults suffering from head and neck cancer in the US? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 135(4), 475–480. https://doi.org/10.1016/j.oooo.2022.08.001
Publication Date
Columbia Affiliation
Puram, S. V., Mints, M., Pal, A., Qi, Z., Reeb, A., Gelev, K., Barrett, T. F., Gerndt, S., Liu, P., Parikh, A. S., Ramadan, S., Law, T., Mroz, E. A., Rocco, J. W., Adkins, D., Thorstad, W. L., Gay, H. A., Ding, L., Paniello, R. C., … Tirosh, I. (2023). Cellular states are coupled to genomic and viral heterogeneity in HPV-related oropharyngeal carcinoma. Nature Genetics, 55(4), 640–650. https://doi.org/10.1038/s41588-023-01357-3
Publication Date
Mezghani, N., Yao, A., Vasilyeva, D., Kaplan, N., Shackelford, A., Yoon, A., Phillipone, E., Dubey, S., Schwartz, G. K., Taylor, A. M., & Momen-Heravi, F. (2022). Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. Clinical Cancer Research, 29(5), 910–920. https://doi.org/10.1158/1078-0432.ccr-22-2258
Publication Date
Parikh, A. S., Yu, V. X., Flashner, S., Okolo, O. B., Lu, C., Henick, B. S., Momen-Heravi, F., Puram, S. V., Teknos, T., Pan, Q., & Nakagawa, H. (2023). Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer. Oral Oncology, 138, 106330. https://doi.org/10.1016/j.oraloncology.2023.106330
Publication Date
Flashner, S., Martin, C., Matsuura, N., Shimonosono, M., Tomita, Y., Morimoto, M., Okolo, O., Yu, V. X., Parikh, A. S., Klein-Szanto, A. J. P., Yan, K., Gabre, J. T., Lu, C., Momen-Heravi, F., Rustgi, A. K., & Nakagawa, H. (2022). Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids. Journal of Visualized Experiments, 190. https://doi.org/10.3791/64676
Publication Date
Li, D., Thomas, C., Shrivastava, N., Gersten, A., Gadsden, N., Schlecht, N., Kawachi, N., Schiff, B. A., Smith, R. V., Rosenblatt, G., Augustine, S., Gavathiotis, E., Burk, R., Prystowsky, M. B., Guha, C., Mehta, V., & Ow, T. J. (2023). Establishment of a diverse head and neck squamous cancer cell bank using conditional reprogramming culture methods. Journal of Medical Virology, 95(2). Portico. https://doi.org/10.1002/jmv.28388
Publication Date
Kao, D. D., Ferrandino, R. M., Bauml, J. M., Marshall, D. C., Bakst, R., Roof, S., Park, Y.-H. A., & Sigel, K. M. (2022). Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck. Oral Oncology, 135, 106216. https://doi.org/10.1016/j.oraloncology.2022.106216
Publication Date
Tanagala, K. K. K., Morin-Baxter, J., Carvajal, R., Cheema, M., Dubey, S., Nakagawa, H., Yoon, A., Cheng, Y.-S. L., Taylor, A., Nickerson, J., Mintz, A., & Momen-Heravi, F. (2022). SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. Journal for ImmunoTherapy of Cancer, 10(12), e005088. https://doi.org/10.1136/jitc-2022-005088
Publication Date
Farrokhian, N., Holcomb, A. J., Dimon, E., Karadaghy, O., Ward, C., Whiteford, E., Tolan, C., Hanly, E. K., Buchakjian, M. R., Harding, B., Dooley, L., Shinn, J., Wood, C. B., Rohde, S., Khaja, S., Parikh, A., Bulbul, M. G., Penn, J., Goodwin, S., & Bur, A. M. (2022). Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery, 148(10), 947. https://doi.org/10.1001/jamaoto.2022.2312
Publication Date
Obradovic, A., Graves, D., Korrer, M., Wang, Y., Roy, S., Naveed, A., Xu, Y., Luginbuhl, A., Curry, J., Gibson, M., Idrees, K., Hurley, P., Jiang, P., Liu, X. S., Uppaluri, R., Drake, C. G., Califano, A., & Kim, Y. J. (2022). Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer. Clinical Cancer Research, 28(10), 2094–2109. https://doi.org/10.1158/1078-0432.ccr-21-3570
Publication Date